GT
PHAS

Glenmede Trust’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Glenmede Trust’s Portfolio PHAS Stock Details PHAS Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-5,000
Closed -$20 – 3164
2019
Q3 		$20 Hold
5,000
– – ﹤0.01% 2049
2019
Q2 		$65 Buy
+5,000
New +$65 ﹤0.01% 1557